The use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rapidly given recent advances in technology, even though there is controversy regarding the evidence justifying its use. Because ECMO is a complex, high-risk, and costly modality, at present it should be conducted in centers with sufficient experience, volume, and expertise to ensure it is used safely. This position paper represents the consensus opinion of an international group of physicians and associated health-care workers who have expertise in therapeutic modalities used in the treatment of patients with severe ARF, with a focus on ECMO. The aim of this paper is to provide physicians, ECMO center directors and coordinators, hospital directors, health-care organizations, and regional, national, and international policy makers a description of the optimal approach to organizing ECMO programs for ARF in adult patients. Importantly, this will help ensure that ECMO is delivered safely and proficiently, such that future observational and randomized clinical trials assessing this technique may be performed by experienced centers under homogeneous and optimal conditions. Given the need for further evidence, we encourage restraint in the widespread use of ECMO until we have a better appreciation for both the potential clinical applications and the optimal techniques for performing ECMO.
The use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rapidly given recent advances in technology, although there is controversy regarding the evidence justifying its use (1) (2) (3) (4) (5) (6) (7) (8) (9) . The recent experience in 2009 using ECMO for pandemic influenza A (H1N1)-associated acute respiratory distress syndrome (ARDS) revealed that many centers initiated ECMO programs without significant experience and with variable results (7, (9) (10) (11) (12) (13) (14) (15) (16) . Because ECMO is a complex, high-risk, and costly modality, at present it should be conducted in centers with sufficient experience, volume, and expertise to ensure it is used safely. Additionally, further clinical trials are essential for identifying and clarifying the indications, contraindications, and techniques for use of this technology.
Purpose of this Position Paper
This position paper represents the consensus opinion of an international group of physicians and associated health-care workers who have expertise in therapeutic modalities used in the treatment of patients with severe ARF, with a focus on ECMO. The aim of this paper is to provide physicians, ECMO center directors and coordinators, hospital directors, health-care organizations, and regional, national, and international policy makers a description of the optimal approach to organizing ECMO programs for ARF in adult patients. This will help ensure that ECMO is delivered safely and proficiently at centers capable of both providing high-quality ECMO and participating in high-impact clinical research. It is of the utmost importance to ensure that future observational and randomized clinical trials assessing this technique be performed by experienced centers under homogeneous and optimal conditions Given the need for further evidence, we encourage restraint in the widespread use of ECMO until we have a better appreciation for both the potential clinical applications and the optimal techniques for performing ECMO.
Definitions
Extracorporeal life support (ECLS) systems are mechanical devices designed to temporarily support the failing heart or lungs (17) . They differ from cardiopulmonary bypass systems used in the operating room for very short-term support during surgery in both their configuration and intent. The term ECMO is often used interchangeably with ECLS, as we will use it here, although it denotes a form of ECLS in which the primary purpose is to provide blood oxygenation. There are two anatomic approaches that are used to implement ECMO: venoarterial (VA) and venovenous (VV). Virtually all applications are variations on these.
d VA ECMO drains the blood from the right atrium via a femoral venous or internal jugular venous cannula or, in patients with an open chest, directly from the right atrium (17) . The blood is pumped through a membrane oxygenator allowing oxygen to be added and carbon dioxide to be removed. After passing through the oxygenator, blood is then actively pumped into the arterial system either via a cannula placed in a peripheral artery, usually femoral or subclavian (closed chest), or directly into the aorta (open chest). VA ECLS is typically a high blood flow extracorporeal circuit that can pump up to 7 L/min and provide full or partial cardiopulmonary support (18) (19) (20) (21) (22) (23) (24) (25) . VA ECMO is a closed system, which differs from standard cardiopulmonary bypass used in the operating room, which is an open system with a blood-air interface. d VV ECMO drains blood from the venae cavae via a femoral venous or right internal jugular venous cannula (17) . The blood is, once again, pumped through a membrane oxygenator; however, in this case it is returned to the venous system either via a femoral venous or right internal jugular venous cannula. A single bicaval double-lumen cannula inserted in the internal jugular vein can be used for venous drainage (26) . VV ECMO is a high blood flow (up to 7 L/min in some cases) extracorporeal circuit that may provide full or partial extracorporeal pulmonary support (1, 7, 8, 11, 14, 16, (27) (28) (29) (30) (31) (32) (33) where ECMO is offered as part of a larger management protocol for ARF, may be associated with improved outcomes (7, 8) . This is also consistent with the literature on the number of mechanically ventilated ICU patients, where again, the more cases a center performs, the better the outcome (37 
Physical Facilities and Equipment
The equipment that should be readily available is listed in Table 1 . Importantly, a wet-primed circuit should be available for immediate use around the clock, because there is some evidence that an assembled circuit can be stored for up to a few days to weeks (54) without presenting an additional risk of infection. It should be possible to change the ECMO circuit in considerably less than, but not exceeding, 15 minutes in cases of sudden malfunction. In highvolume centers, primed circuits are routinely used in much less time, a further advantage to concentrating volume. Table 2 lists medical-surgical and laboratory personnel from the permanent hospital staff who should be available 24 hours a day. The ECMO center should be able to provide emergency access (,30 min) to cardiovascular or thoracic surgery, abdominal surgery, 
Non-ICU Support Services
Definition of abbreviation: ECMO = extracorporeal membrane oxygenation.
esophagogastroduodenal endoscopic interventions, and interventional radiology. A biomedical engineer should maintain ECMO equipment on a regular basis. Staff responsible for data collection should maintain the appropriate databases. Nonemergent services, such as pastoral and palliative care or other patient and family support services, should be available. 
Staff Training and Continuing Education

Research
There is a clear need for further randomized, controlled trials and other high-level evidence with respect to the use of ECMO in ARF. These data will help guide clinicians with respect to specific indications and contraindications of the various techniques. As the number of ECMO cases is relatively small at each center, national and international organizations of ECMO centers (such as ELSO and the International ECMO Network) are vital to promote research activity and further advance our knowledge. The International ECMO Network is a growing consortium of ECMO-proficient centers and individuals dedicated to undertaking high-quality, highimpact research in the field. By ensuring that expert centers adhere to current best practices for the organization and conduct of their ECMO programs, this group hopes to foster an environment conducive to the highest-quality evidence.
The currently ongoing ECMO to Rescue Lung Injury in Severe ARDS (EOLIA) trial (NCT01470703) (56) , an international multicenter, randomized controlled trial comparing mechanical ventilation with or without ECMO in cases of severe ARDS, is a very good example of the ECMO community coming together to build on the current body of literature. The International ECMO Network hopes to expeditiously and responsibly support further research in various applications of ECMO in all forms of ARF.
Conclusions
The role of ECMO for patients with severe ARF has not been definitively established, and further studies are needed to evaluate its impact (56) . The standardization of current best practices and the accumulation of experience at high-quality centers will facilitate the conduct of future research. In the meantime, optimization of conventional treatments (such as low-volume, lowpressure, lung-protective ventilation or prone positioning) should always be undertaken before considering ECMO in patients with severe ARDS. Because the successful delivery of ECMO requires highly experienced staff and a minimum number of cases per year, organization of ECMO programs on a regional or national level is needed to provide the best, safest, and most efficient care possible to the population. Local, regional, or interregional networks of hospitals with a mobile ECMO team should ideally be created around each ECMO center; such a system has recently successfully been organized in a few countries (41) (42) (43) . Staff training and continuing education as well as regular audits evaluating program performance should be routinely organized to assure quality. We believe that this initiative will result in better quality of care, although it will require energy and motivation to encompass many logistical and political challenges. We recognize, however, that differences in hospital policies and national regulations may result in variations in the models for ECMO programs caring for patients with severe ARF. n
